close

Clinical Trials

1 2 3 4 5 195
Number of results: 3895

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-06-16 tisotumab vedotin (HuMax-TF-ADC) solid tumors (ovarian cancer, cervical cancer, endometrium cancer, bladder cancer, prostate cancer, esophageal cancer, lung cancer) 1-2 Genmab (Denmark) Cancer - Oncology
2017-06-16 ADCT-402 relapsed or refractory non-Hodgkin's lymphoma 1 ADC Therapeutics (Switzerland) Cancer - Oncology
2017-06-15 OSE-127 (Effi-7) ulcerative colitis preclinical OSE Immunotherapeutics (France) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2017-06-15 GLS-5700 Zika virus infection 1 Inovio Pharmaceuticals (USA - PA) Infectious diseases
2017-06-14 pracinostat myelodysplastic syndrome (MDS) 2 Mei Pharma (USA - CA) Helsinn Group (Switzerland) Cancer - Oncology
2017-06-14 vobarilizumab (ALX-0061) moderate to severe rheumatoid arthritis 2b Ablynx (Belgium) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2017-06-14 vobarilizumab (ALX-0061) moderate to severe rheumatoid arthritis 2b Ablynx (Belgium) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2017-06-14 ARGX-110 relapsed/refractory cutaneous T-cell lymphoma (CTCL) 1b Argen-X (Belgium - The Netherlands) Cancer - Oncology
2017-06-13 Victoza® (liraglutide) type 2 diabetes Novo Nordisk (Denmark) Metabolic diseases
2017-06-12 imeglimin type 2 diabetes preclinical Poxel (France) Metabolic diseases
2017-06-11 PQ912 Alzheimer’s Disease 2a Probiodrug (Germany) Neurodegenerative diseases
2017-06-10 MYL-1501D (biosimilar version of insulin glargin) type 1 diabetes, type 2 diabetes 3 Mylan (USA - PA) Biocon (India) Metabolic diseases
2017-06-10 ZGN-1061 patients with type 2 diabetes who are overweight or obese 1 Zafgen (USA - MA) Metabolic diseases
2017-06-10 ertugliflozin type 2 diabetes 3 Merck&Co (USA - NJ) - Pfizer (USA - NY) Metabolic diseases
2017-06-10 galcanezumab (LY2951742) episodic migraine, chronic migraine 3 Eli Lilly (USA - IN) CNS diseases - Neurological diseases
2017-06-10 Soliqua®/iGlarLixi® (single injection Lyxumia®(lixisenatide) /Lantus® (insuline glargine) combination product diabetes 3 Sanofi (France) Zealand Pharma (Denmark) Metabolic diseases
2017-06-09 Orkambi® (lumacaftor in combination with ivacaftor ) cystic fibrosis 3 Vertex Pharmaceuticals (USA - MA) Rare diseases - Genetic diseases
2017-06-09 Xilonix™ advanced colorectal cancer 3 XBiotech (USA - TX) Cancer - Oncology
2017-06-09 Orkambi® (lumacaftor in combination with ivacaftor ) children with cystic fibrosis (CF) ages 6 through 11 who have two copies of the F508del mutation 3 Vertex Pharmaceuticals (USA - MA) Rare diseases - Genetic diseases
2017-06-09 Xtandi® (enzalutamide) non metastatic castration-resistant prostate cancer 3 Medivation (USA - CA), now Pfizer (USA - NY) Astellas (Japan) Cancer - Oncology